Objectives: To determine owner's perception of their pet's quality of life during treatment with carboplatin for a variety of canine and feline neoplasms. Methods: Owners were contacted via a postal questionnaire and asked questions regarding their perception of chemotherapy in pets and their perception of carboplatin treatment in their pet. Results: Twenty‐eight (59%) of owners responded to the questionnaire. Forty‐three percent of owners had not considered chemotherapy in pets before treatment; however, after treatment, 89% of owners supported its use. Sixteen (57%) patients had mild to severe side effects. Most patients experienced mild side effects, including lethargy and loss of appetite. Quality of life during treatment was reduced compared with prediagnosis quality of life however at its best was significantly improved compared with pretreatment quality of life. Eighty‐nine per cent of respondents did not regret treating their pet. Clinical Significance: Carboplatin is well tolerated by both owners and pets. Most patients have either no side effects or experience mild lethargy or inappetence. Carboplatin treatment, either alone or in conjunction with other medications, should be considered as a palliative treatment in both dogs and cats with susceptible neoplasms.
IntroductionWork‐related musculoskeletal disorders (WRMSD) are defined as injury or pain resulting from work and are common in qualified sonographers, affecting the shoulder, neck, wrist, and hands. Risk factors include poor ergonomics, work flow, inadequate breaks, and psychological stress. WRMSD carries a significant financial and emotional cost to industry. The incidence of WRMSD in Australian trainee sonographers is unknown. The aim of this research is to identify the incidence and distribution of WRMSD in trainee sonographers.MethodThis is a prospective observational study. An anonymous online survey was distributed to final‐year medical sonography students, and participation was voluntary and based on self‐selection.ResultsThere were 35/86 respondents, a 40.7% response rate. The incidence of WRMSD was 97%. Age, body mass index, height, gender, time spent scanning/day, and number of scans performed/day were not found to be associated with the development of WRMSD. The scanning shoulder, wrist, neck, and back were most commonly affected.ConclusionWRMSD incidence and distribution in Australian trainees are similar to that of qualified sonographers. It is therefore important to begin preventative measures early on in sonographer training to help minimise WRMSD developing.
Introduction: Mammography is the standard screening modality for breast cancer; however, sensitivity reduces with increasing breast density, resulting in the potential for masking of cancer. Ultrasound is a potential supplemental screening tool, but its routine use is controversial. Methods: A database search was performed with keywords ''ultrasound'' and ''breast density and screening'', including variations. Articles were included if they assessed the use of hand-held ultrasound as a supplemental screening modality in women with dense breasts. Discussion: Twelve articles were identified. No high-level evidence articles were identified. Cancer detection rates increased with the addition of ultrasound-to-mammography screening protocols. However, this was associated with increased costs per cancer detected, an increased biopsy rate, and a low positive predictive value. The survival benefit, cost versus benefit, and psychological impact of the addition of ultrasound is unknown. Conclusions: The addition of ultrasound to a screening program in an asymptomatic population of women with dense breast tissue detects additional cancers compared with mammography alone. Knowledge regarding a survival or cost benefit associated with increased cancer detection, and the psychological impact of the addition of ultrasound is unknown. Further research is needed to assess whether the addition of ultrasound is cost-effective with respect to clinical outcome and survival.
A 1-year-old oriental cat was presented with a peracute onset of tetraparesis and vocalisation. Clinical findings were suggestive of multi-site thromboembolic disease, and this was confirmed on post-mortem examination. An echocardiogram showed severe restrictive cardiomyopathy and spontaneous echogenic contrast. To the author's knowledge, this is the first reported case of tetraparesis secondary to cardiogenic arterial thromboembolic disease. Thromboembolic disease should be included as a differential diagnosis for any cat presented with a peracute onset of paresis or paralysis, even if there is no history of cardiac disease.
Objective To describe a minimally invasive cranial ostectomy for the treatment of impingement of dorsal spinous processes (DSPs) in the standing horse. Study Design Retrospective study. Animals One hundred two horses with impinging DSPs. Methods The case records of all horses that had the described technique between 2011 and 2019 were reviewed. All sites of impinging DSPs were treated under standing sedation and local anesthesia. The minimally invasive cranial ostectomy of the caudal DSP was performed with bone rongeurs through multiple small incisions. Results Of the 102 horses treated with this technique, no surgical complications were recorded. Median (range) long‐term follow‐up for all horses was 18 months (12–50 months) postoperatively. Of the 66 horses available for follow‐up that were still alive, 53 horses (80%) had complete resolution of clinical signs and returned to the intended work. There were 36 horses with a concurrent orthopedic issue presurgery, and 25/36 (69%) returned to the same level of intended work; of the horses with no evidence of another orthopedic issue presurgery, 28/30 (93%) returned to the same level of intended work. Conclusion Minimally invasive cranial ostectomy of the caudal DSP had a good success rate in horses with impingment of DSPs. Clinical Significance The described minimally invasive ostectomy technique in standing horses is a low‐risk procedure that provides success rates similar to other techniques.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.